Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
123.24
Dollar change
-3.49
Percentage change
-2.75
%
IndexS&P 500 P/E28.90 EPS (ttm)4.26 Insider Own0.48% Shs Outstand283.59M Perf Week-4.28%
Market Cap34.94B Forward P/E20.46 EPS next Y6.02 Insider Trans-0.67% Shs Float282.15M Perf Month2.45%
Enterprise Value36.81B PEG3.67 EPS next Q1.58 Inst Own91.78% Short Float1.08% Perf Quarter3.64%
Income1.22B P/S5.15 EPS this Y5.35% Inst Trans0.92% Short Ratio1.81 Perf Half Y5.04%
Sales6.79B P/B5.49 EPS next Y8.08% ROA10.51% Short Interest3.04M Perf YTD-8.26%
Book/sh22.46 P/C22.76 EPS next 5Y7.88% ROE19.88% 52W High153.84 -19.89% Perf Year-10.72%
Cash/sh5.41 P/FCF32.11 EPS past 3/5Y3.97% 5.63% ROIC12.55% 52W Low96.43 27.80% Perf 3Y-6.23%
Dividend Est.0.98 (0.80%) EV/EBITDA20.00 Sales past 3/5Y1.00% 4.75% Gross Margin52.98% Volatility2.06% 2.26% Perf 5Y27.26%
Dividend TTM0.98 (0.80%) EV/Sales5.42 EPS Y/Y TTM-11.52% Oper. Margin22.91% ATR (14)2.97 Perf 10Y244.73%
Dividend Ex-DateJul 01, 2025 Quick Ratio1.71 Sales Y/Y TTM4.48% Profit Margin17.97% RSI (14)51.74 Recom2.24
Dividend Gr. 3/5Y6.42% 7.33% Current Ratio2.25 EPS Q/Q21.66% SMA200.27% Beta1.26 Target Price138.50
Payout21.31% Debt/Eq0.54 Sales Q/Q10.14% SMA503.02% Rel Volume0.74 Prev Close126.73
Employees17900 LT Debt/Eq0.53 EarningsAug 27 AMC SMA200-0.41% Avg Volume1.68M Price123.24
IPONov 18, 1999 Option/ShortYes / Yes EPS/Sales Surpr.0.12% 3.17% Trades Volume1,250,800 Change-2.75%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Upgrade Barclays Underweight → Equal Weight $135 → $145
Aug-28-24Initiated Wells Fargo Overweight $157
Jul-10-24Upgrade Citigroup Neutral → Buy $135 → $150
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24Resumed Jefferies Hold $135
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Sep-11-25 04:15PM
02:19PM
Sep-09-25 08:00AM
12:02AM
Sep-04-25 11:31PM
11:40AM Loading…
Sep-03-25 11:40AM
08:00AM
01:31AM
Sep-02-25 08:00AM
Sep-01-25 09:15AM
Aug-28-25 02:43PM
01:59PM
09:56AM
03:06AM
Aug-27-25 06:36PM
05:30PM Loading…
05:30PM
05:20PM
04:40PM
04:30PM
04:05PM
04:03PM
Aug-26-25 06:42PM
Aug-25-25 11:02PM
Aug-22-25 02:25PM
09:15AM
Aug-21-25 04:15PM
07:16AM
Aug-20-25 08:00AM
Aug-19-25 06:40PM
04:54PM
11:40AM Loading…
Aug-18-25 11:40AM
Aug-14-25 10:07AM
09:15AM
07:20AM
Aug-13-25 11:18AM
08:25AM
08:00AM
Aug-07-25 05:40PM
Aug-04-25 08:00AM
06:27AM
Jul-30-25 05:48AM
Jul-29-25 09:10AM
Jul-28-25 09:00PM
11:30AM
Jul-24-25 03:30PM
08:27AM
Jul-21-25 04:08AM
Jul-17-25 04:30PM
12:59PM
10:42AM
Jul-15-25 08:30AM
Jul-14-25 03:20PM
08:30AM
Jul-08-25 06:24AM
Jul-07-25 09:54AM
12:03AM
Jun-30-25 12:43PM
Jun-27-25 11:30AM
Jun-24-25 01:40AM
Jun-19-25 08:30AM
Jun-18-25 06:00AM
Jun-16-25 11:31PM
Jun-12-25 08:00AM
Jun-02-25 09:15AM
May-30-25 09:11AM
May-29-25 04:23PM
02:49PM
10:13AM
09:21AM
09:15AM
03:04AM
May-28-25 11:22PM
05:32PM
05:30PM
05:20PM
04:58PM
04:21PM
04:15PM
04:05PM
08:30AM
May-27-25 08:01AM
08:00AM
03:02AM
May-25-25 05:00AM
May-22-25 09:01PM
09:15AM
May-21-25 04:05PM
08:30AM
May-20-25 08:00AM
May-15-25 04:14PM
May-14-25 08:50AM
May-12-25 07:25PM
May-08-25 12:35AM
May-05-25 07:40AM
12:41AM
May-02-25 12:10PM
May-01-25 08:00AM
Apr-30-25 09:50PM
09:01AM
Apr-29-25 09:05AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McMahon Robert W.Former OfficerSep 09 '25Proposed Sale126.215,781729,591Sep 09 04:26 PM
McMahon Robert W.Former OfficerSep 04 '25Proposed Sale128.6215,3031,968,224Sep 04 04:39 PM
MCDONNELL PADRAIGPresident and CEOSep 02 '25Sale124.882,000249,76033,448Sep 04 03:36 PM
MCDONNELL PADRAIGOfficerSep 02 '25Proposed Sale124.882,000249,760Sep 02 03:30 PM
McMahon Robert W.Former OfficerAug 29 '25Proposed Sale124.9628,0813,508,993Aug 29 03:46 PM
Ancher-Jensen HenrikFormer OfficerAug 29 '25Proposed Sale125.0421,6442,706,366Aug 29 09:59 AM
MCDONNELL PADRAIGPresident and CEOAug 01 '25Sale113.452,000226,90035,448Aug 04 04:15 PM
MCDONNELL PADRAIGOfficerAug 01 '25Proposed Sale113.452,000226,900Aug 01 10:32 AM
MCDONNELL PADRAIGPresident and CEOJul 01 '25Sale117.441,508177,10037,448Jul 03 04:46 PM
MCDONNELL PADRAIGOfficerJul 01 '25Proposed Sale117.441,508177,100Jul 01 12:45 PM
Brown Judy LDirectorJun 18 '25Sale116.5389041,677Jun 23 12:12 PM
Podolsky Daniel KDirectorMar 31 '25Sale116.461,819211,84435,737Apr 02 05:07 PM
Podolsky Daniel KDirectorMar 31 '25Proposed Sale116.461,819211,845Mar 31 01:21 PM
Gonsalves RodneyV.P., Corporate ControllerMar 17 '25Sale121.981,908232,69121,786Mar 18 02:17 PM
Gonsalves RodneyOfficerMar 17 '25Proposed Sale121.961,908232,692Mar 17 03:14 PM
Rataj Sue H.DirectorMar 06 '25Sale126.386,971881,00919,640Mar 07 04:11 PM
Rataj Sue H.DirectorMar 06 '25Proposed Sale126.386,971881,005Mar 06 02:27 PM
MCDONNELL PADRAIGPresident and CEOJan 21 '25Sale150.001,911286,65039,652Jan 23 07:20 PM
MCDONNELL PADRAIGOfficerJan 21 '25Proposed Sale150.001,911286,650Jan 21 10:53 AM
MCDONNELL PADRAIGPresident and CEOSep 27 '24Sale150.00477,05024,071Sep 30 01:08 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.009,9901,448,55040,011Sep 27 05:02 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.005,010726,45046,762Sep 27 05:02 PM
MCDONNELL PADRAIGOfficerSep 27 '24Proposed Sale150.00477,050Sep 27 12:19 PM
Grau DominiqueOfficerSep 26 '24Proposed Sale145.0015,0002,175,000Sep 26 02:52 PM